Ads
related to: hypertrophic obstructive cardiomyopathy- General HCP Information
Learn About A Treatment Option For
NYHA Class II-III oHCM.
- LVOT Obstruction
Valsalva Maneuver Video
For Assessing HCM Patients
- Efficacy And Safety
Review Data Points And
Trial Outcomes Today.
- Learn About oHCM
Watch This Video To
Learn About oHCM Symptoms
- General HCP Information
Search results
Results From The WOW.Com Content Network
Hypertrophic cardiomyopathy (HCM, or HOCM when obstructive) is a condition in which muscle tissues of the heart become thickened without an obvious cause. [8] The parts of the heart most commonly affected are the interventricular septum and the ventricles. [10]
Hypertrophic cardiomyopathy can be a deadly disease, and there was a time when it was largely untreatable. ... among patients with obstructive forms of hypertrophic cardiomyopathy—either with or ...
Hypertrophic cardiomyopathy affects about 1 in 500 people while dilated cardiomyopathy affects 1 in 2,500. [ 3 ] [ 10 ] They resulted in 354,000 deaths up from 294,000 in 1990. [ 7 ] [ 11 ] Arrhythmogenic right ventricular dysplasia is more common in young people.
Alcohol septal ablation (ASA) is a minimally invasive heart procedure to treat hypertrophic cardiomyopathy (HCM). [1]It is a percutaneous, minimally invasive procedure performed by an interventional cardiologist to relieve symptoms and improve functional status in eligible patients with severely symptomatic HCM who meet strict clinical, anatomic and physiologic selection criteria.
Mavacamten, sold under the brand name Camzyos, is a medication used to treat obstructive hypertrophic cardiomyopathy. [8] [9] Mavacamten is a small-molecule allosteric [10] and cardiac myosin inhibitor. [8] It was developed by MyoKardia, a subsidiary of Bristol Myers Squibb. [11]
Septal myectomy is associated with a low perioperative mortality and a high late survival rate. A study at the Mayo Clinic found surgical myectomy performed to relieve outflow obstruction and severe symptoms in HCM was associated with long-term survival equivalent to that of the general population, and superior to obstructive HCM without operation.
Ads
related to: hypertrophic obstructive cardiomyopathy